期刊文献+

Identifying Factors that Affect the Probability of Being Cured from MDR-TB Disease, KwaZulu-Natal, South Africa: A Competing Risks Analysis

Identifying Factors that Affect the Probability of Being Cured from MDR-TB Disease, KwaZulu-Natal, South Africa: A Competing Risks Analysis
下载PDF
导出
摘要 Setting: Four decentralised sites are located in rural areas and one centralised hospital in KwaZulu-Natal province, South Africa. Objective: To analyse risk factors associated with multidrug-resistant tuberculosis (MDR-TB) using competing risks analysis. Understanding factors associated with MDR-TB and obtaining valid parameter estimates could help in designing control and intervention strategies to lower TB mortality. Method: A prospective study was performed using a competing risk analysis in patients receiving treatment for MDR-TB. The study focused on 1542 patients (aged 18 years and older) who were diagnosed of MDR-TB between July 2008 and June 2010. Time to cure MDR-TB was used as the dependent variable and time to death was the competing risk event. Results: The Fine-Gray regression model indicated that baseline weight was highly significant with sub-distribution hazard ration (SHR) = 1.02, 95% CI: 1.01 - 1.02. This means that weight gain in a month increased chances of curing MDR-TB by 2%. Results show that lower chances to cure MDR-TB were among patients between 41 to 50 years compared to those patients who were between 18 to 30 years old (SHR = 0.80, 95% CI: 0.61 - 1.06). The chances of curing MDR-TB in female patients were low compared to male patients (SHR = 0.84, 95% CI = 0.68 - 1.03), however this was not significant. Furthermore, HIV negative patients had higher chances to cure MDR-TB (SHR = 1.07, 95% CI: 0.85 - 1.35) compared to HIV positive patients. Patients who were treated in the decentralised sites had lower chances to be cured of MDR-TB (SHR = 0.19, 95% CI: 0.07 - 0.54) as compared to patients who were treated in the centralised hospital. Conclusion: Identifying key factors associated with TB and specifying strategies to prevent them can reduce mortality of patients due to TB disease, hence positive treatment outcomes leading to the goal of reducing or end TB deaths. Urgent action is required to improve the coverage and quality of diagnosis, treatment and care for people with drug-resistant Setting: Four decentralised sites are located in rural areas and one centralised hospital in KwaZulu-Natal province, South Africa. Objective: To analyse risk factors associated with multidrug-resistant tuberculosis (MDR-TB) using competing risks analysis. Understanding factors associated with MDR-TB and obtaining valid parameter estimates could help in designing control and intervention strategies to lower TB mortality. Method: A prospective study was performed using a competing risk analysis in patients receiving treatment for MDR-TB. The study focused on 1542 patients (aged 18 years and older) who were diagnosed of MDR-TB between July 2008 and June 2010. Time to cure MDR-TB was used as the dependent variable and time to death was the competing risk event. Results: The Fine-Gray regression model indicated that baseline weight was highly significant with sub-distribution hazard ration (SHR) = 1.02, 95% CI: 1.01 - 1.02. This means that weight gain in a month increased chances of curing MDR-TB by 2%. Results show that lower chances to cure MDR-TB were among patients between 41 to 50 years compared to those patients who were between 18 to 30 years old (SHR = 0.80, 95% CI: 0.61 - 1.06). The chances of curing MDR-TB in female patients were low compared to male patients (SHR = 0.84, 95% CI = 0.68 - 1.03), however this was not significant. Furthermore, HIV negative patients had higher chances to cure MDR-TB (SHR = 1.07, 95% CI: 0.85 - 1.35) compared to HIV positive patients. Patients who were treated in the decentralised sites had lower chances to be cured of MDR-TB (SHR = 0.19, 95% CI: 0.07 - 0.54) as compared to patients who were treated in the centralised hospital. Conclusion: Identifying key factors associated with TB and specifying strategies to prevent them can reduce mortality of patients due to TB disease, hence positive treatment outcomes leading to the goal of reducing or end TB deaths. Urgent action is required to improve the coverage and quality of diagnosis, treatment and care for people with drug-resistant
作者 Sizwe Vincent Mbona Henry Mwambi Retius Chifurira Sizwe Vincent Mbona;Henry Mwambi;Retius Chifurira(Statistics Department, Durban University of Technology, Durban, South Africa;School of Mathematics, Statistics and Computer Science, University of KwaZulu-Natal, Pietermaritzburg, South Africa;School of Mathematics, Statistics and Computer Science, University of KwaZulu-Natal, Westville, South Africa)
出处 《Journal of Tuberculosis Research》 2022年第1期1-17,共17页 结核病研究(英文)
关键词 Competing Risks MDR-TB South Africa Competing Risks MDR-TB South Africa
  • 相关文献

参考文献1

二级参考文献50

  • 1Sacks LV,Behrman RE.Developing new drugs for the treat ment of drug-resistant tuberculosis:a regulatory perspective. Tuberculosis . 2008 被引量:1
  • 2Pai M,Kalantri S,Dheda K.New tools and emerging technologies for the diagnosis of tuberculosis.Part II.Active tuberculosis and drug resistance. Expert Review of Molecular Diagnostics . 2006 被引量:1
  • 3World Health Organization Stop TB Depart ment.Guide-lines for the programmatic management of drug-resistant tuberculosis. WHO/HTM/TB/2008.402 . 2008 被引量:1
  • 4Orenstein EW,Basu S,Shah NS,et al.Treat ment out-comes among patients with multidrug-resistant tuberculo-sis:systematic review and meta-analysis. The Lancet Infectious Diseases . 2009 被引量:1
  • 5Johnston JC,Shahidi NC,Sadatsafavi M,Fitzgerald J M.Treat ment outcomes of multidrug-resistant tubercu-losis:a systematic review and meta-analysis. PLoS One . 2009 被引量:1
  • 6Klii man K,Altraja A.Predictors of poor treat ment out-come in multi-and extensively drug-resistant pul monary TB. European Respiratory Journal . 2009 被引量:1
  • 7Wells CD,Cegielski JP,Nelson LJ,et al.HIVinfection and multidrug-resistant tuberculosis:the perfect storm. The Journal of Infectious Diseases . 2007 被引量:1
  • 8World Health Organization.Prevention and control of multidrug-resistant tuberculosis and extensively drug-re-sistant tuberculosis. 62nd World Health Assembly WHA62.15 . 2009 被引量:1
  • 9Dunn D,Babiker A,Hooker M,Darbyshire J.The dan-gers of inferring treat ment effects fromobservational da-ta:a case study in HIV infection. Controlled Clinical Trials . 2002 被引量:1
  • 10Phillips AN,Grabar S,Tassie J M,Costagliola D,Lun-dgren JD,Egger M.Use of observational databases to e-valuate the effectiveness of antiretroviral therapyfor HIV infection:comparison of cohort studies with randomized trials. AIDS . 1999 被引量:1

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部